| Not Yet Recruiting | Electroconvulsive Therapy for Treatment of Alzheimer´s Disease NCT02438202 | Central Institute of Mental Health, Mannheim | N/A |
| Not Yet Recruiting | A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects NCT06964230 | T3D Therapeutics, Inc. | Phase 2 / Phase 3 |
| Not Yet Recruiting | LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response NCT07459959 | Johns Hopkins University | Phase 1 / Phase 2 |
| Not Yet Recruiting | CommunityRx-Dementia + Peer Navigation (CRxDpeer) NCT07346183 | University of Chicago | N/A |
| Recruiting | PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairme NCT07169630 | National Institute of Mental Health (NIMH) | Phase 1 |
| Not Yet Recruiting | The Underlying Neural Mechanism of TMS in Improving the Imbalance of "Microbiota-brain-gut Axis" in Alzheimer NCT07346794 | Second Affiliated Hospital of Nanchang University | N/A |
| Not Yet Recruiting | Assessment of Malnutrition in Hospitalized Patients: a Quasi Study NCT07473492 | AlFayhaa General Hospital | — |
| Not Yet Recruiting | Adaptation of the Mini-Mental State Examination (MMSE) for the Reunion Island Population NCT07251647 | Centre Hospitalier Universitaire de la Réunion | N/A |
| Recruiting | Dementia in Fiction and Clinical Narratives NCT07482800 | Fu Jen Catholic University | — |
| Not Yet Recruiting | An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Dise NCT07258004 | University of the West of Scotland | N/A |
| Not Yet Recruiting | Use of Wearables for Identifying Factors Associated With Mild Cognitive Impairment and Early-Stage Alzheimer's NCT07391436 | Getúlio Vargas University Hospital | — |
| Not Yet Recruiting | A Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's NCT07485153 | Eli Lilly and Company | — |
| Enrolling By Invitation | WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT NCT07250113 | Northwell Health | N/A |
| Recruiting | Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkins NCT07467460 | Neuromed IRCCS | — |
| Recruiting | Lombard Cohort of Brain Health Services NCT07457138 | University of Milano Bicocca | — |
| Not Yet Recruiting | The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) NCT07367880 | University Hospital, Grenoble | — |
| Recruiting | Fisetin in Mild Alzheimer's Disease NCT07279714 | Sunnybrook Health Sciences Centre | Phase 2 |
| Recruiting | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Partic NCT07234942 | Hoffmann-La Roche | Phase 1 |
| Not Yet Recruiting | Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study NCT07332260 | University Hospital of North Norway | Phase 1 |
| Recruiting | Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia NCT07279740 | Sunnybrook Health Sciences Centre | Phase 2 |
| Recruiting | Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study NCT07224607 | Cedars-Sinai Medical Center | N/A |
| Recruiting | Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A) NCT07262645 | Danyang Huichuang Medical Equipment Co., Ltd. | Phase 3 |
| Recruiting | Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition NCT07265323 | Pennington Biomedical Research Center | N/A |
| Not Yet Recruiting | A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease NCT07301502 | Akeso | Phase 1 |
| Active Not Recruiting | Art of Memory for Cognitive Enhancement in the Monza Brain Health Service NCT07479914 | University of Milano Bicocca | N/A |
| Recruiting | Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison W NCT07071649 | Centre Hospitalier Universitaire, Amiens | N/A |
| Recruiting | Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicl NCT07361887 | University of Seville | N/A |
| Recruiting | [18F]NIDF PET Imaging in Tau-related Diseases NCT07306598 | Tianjin Medical University | — |
| Recruiting | A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease NCT07214727 | Alnylam Pharmaceuticals | Phase 1 |
| Recruiting | Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease NCT07409506 | Hospices Civils de Lyon | — |
| Recruiting | Open-label Extension Study in Participants With Early Alzheimer's Disease NCT07105709 | GlaxoSmithKline | Phase 2 |
| Enrolling By Invitation | TSPO Modulation in AD NCT07191821 | Imperial College London | Phase 2 |
| Recruiting | A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease NCT07094516 | Novartis Pharmaceuticals | Phase 2 |
| Not Yet Recruiting | A Prospective Multicenter RCT Study of Deep Jugular Lymphovenous Anastomosis in the Treatment of Alzheimer's D NCT07060391 | Shanghai Jiao Tong University School of Medicine | Phase 3 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease NCT06976203 | Bristol-Myers Squibb | Phase 3 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease NCT06976216 | Bristol-Myers Squibb | Phase 3 |
| Enrolling By Invitation | Multisensory Environment-Based Occupational Therapy for Alzheimer's Patients NCT07279103 | Hacettepe University | N/A |
| Recruiting | VR Pupillometry in Cognitive Impairment NCT07402356 | Max-Planck-Institute of Psychiatry | — |
| Recruiting | TREAD: Time Restricted Eating Intervention for Alzheimer's Disease NCT06548191 | University of California, San Diego | Phase 1 |
| Recruiting | Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease NCT07324161 | Fujian Medical University Union Hospital | N/A |
| Not Yet Recruiting | Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alz NCT06868030 | First Hospital of China Medical University | — |
| Recruiting | Pulsed Electromagnetic Field Treatment With Dementia Patients NCT06862557 | Herrick Medical LLC | N/A |
| Terminated | Extension Study of Participants From SPG302-ALZ-101 NCT06833281 | Spinogenix | Phase 2 |
| Recruiting | A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease NCT06810960 | Eisai Korea Inc. | — |
| Recruiting | Effect of Cervical Lymphaticovenous and Lymph Node-to-Vein Anastomosis in Patients With Intracranial Lymphatic NCT07328386 | Hong Joonpio | N/A |
| Enrolling By Invitation | Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs. NCT07234851 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Recruiting | A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors NCT06411561 | University of Washington | N/A |
| Completed | Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3 NCT06595030 | Icahn School of Medicine at Mount Sinai | N/A |
| Recruiting | Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alz NCT06850597 | Medical University of Lodz | Phase 2 |
| Active Not Recruiting | A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) NCT06653153 | Eli Lilly and Company | Phase 3 |
| Completed | A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003) NCT06586606 | Merck Sharp & Dohme LLC | Phase 1 |
| Active Not Recruiting | A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease NCT06602258 | Eisai Inc. | Phase 2 |
| Recruiting | Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and NCT06584357 | GAP Innovations, PBC | — |
| Recruiting | Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease NCT06508268 | Hanze University of Applied Sciences Groningen | — |
| Completed | The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation NCT06234930 | Clarity Health Technologies, Inc | N/A |
| Completed | Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With D NCT06546995 | Neumora Therapeutics, Inc. | Phase 1 |
| Recruiting | Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DI NCT06530732 | Zhejiang Provincial People's Hospital | Phase 3 |
| Recruiting | Blood Biomarkers for Screening of Alzheimer's Disease NCT06477484 | Peking University First Hospital | — |
| Recruiting | Nursing Interventions for Alzheimer's Patients During PET/CT Imaging NCT06784830 | Sichuan Provincial People's Hospital | N/A |
| Active Not Recruiting | DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease NCT06384573 | Washington University School of Medicine | Phase 3 |
| Recruiting | [18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease NCT06833645 | Sichuan Provincial People's Hospital | — |
| Active Not Recruiting | A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodro NCT06402838 | Hoffmann-La Roche | Phase 2 |
| Not Yet Recruiting | Social & Affective Cognition in Alzheimer's Disease & Associated Disorders NCT06338397 | University Hospital, Lille | N/A |
| Enrolling By Invitation | Personalized Brain Stimulation for Cognitive Impairment in Older Adults NCT07208734 | Xuanwu Hospital, Beijing | N/A |
| Unknown | Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function i NCT05578443 | Fujian Medical University Union Hospital | Phase 2 |
| Active Not Recruiting | Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace Oi NCT06245616 | Spanish National Research Council | N/A |
| Not Yet Recruiting | The Treatment of High Intensity Transcranial Current Stimulation for Alzheimer's Disease NCT06380725 | Anhui Provincial Hospital | N/A |
| Completed | Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treat NCT06285240 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1 NCT06356337 | Icahn School of Medicine at Mount Sinai | N/A |
| Recruiting | A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab NCT06322667 | Eisai Co., Ltd. | — |
| Recruiting | Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients NCT06199037 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Di NCT06206824 | Perha Pharmaceuticals | Phase 1 |
| Recruiting | Predictors of Emergency Department Use in Frail Patients NCT07259499 | University of Pisa | — |
| Recruiting | Advances in Telephone-based Cognitive Screening Procedures NCT06337578 | Istituto Auxologico Italiano | — |
| Completed | Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunt NCT05965414 | Artery Therapeutics, Inc. | EARLY_Phase 1 |
| Active Not Recruiting | Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease NCT06079190 | GlaxoSmithKline | Phase 2 |
| Active Not Recruiting | A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology NCT06043700 | Eisai Limited | — |
| Recruiting | An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease NCT05908695 | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Phase 4 |
| Completed | Caregiver Solutions for Dementia Patients NCT05888610 | Prepped Health LLC | N/A |
| Recruiting | Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Deme NCT06088121 | Advanced Technology & Communications | N/A |
| Completed | Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease NCT05811442 | Beijing Joekai Biotechnology LLC | Phase 2 |
| Completed | A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease NCT05804383 | Allyx Therapeutics | Phase 1 |
| Completed | A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Dise NCT05792163 | SciNeuro | Phase 1 |
| Recruiting | Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU) NCT05658913 | University of Pennsylvania | — |
| Withdrawn | SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease NCT05332678 | Seelos Therapeutics, Inc. | Phase 2 |
| Active Not Recruiting | A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZ NCT05738486 | Eli Lilly and Company | Phase 3 |
| Completed | 7T MRI for Light Therapy in Patients With Mild Cognitive Impairment and Mild AD NCT05596994 | Icahn School of Medicine at Mount Sinai | N/A |
| Completed | A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD) NCT05551741 | Immunobrain Checkpoint | Phase 1 |
| Completed | Safety, Tolerability and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients. NCT05681819 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2 NCT05837819 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | [18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease NCT06141356 | Peking Union Medical College Hospital | — |
| Terminated | A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease NCT05744401 | Alector Inc. | Phase 2 |
| Withdrawn | Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease NCT02500784 | Palo Alto Veterans Institute for Research | Phase 2 |
| Recruiting | Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy NCT05655195 | Massachusetts Institute of Technology | N/A |
| Completed | Creatine to Augment Bioenergetics in Alzheimer's NCT05383833 | University of Kansas Medical Center | N/A |
| Unknown | Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Pe NCT05048966 | Kessler Foundation | N/A |
| Completed | Virtual Reality Intervention for the Reduction of Behavioral and Psychological Symptoms of Dementia NCT04769024 | Hospices Civils de Lyon | N/A |
| Terminated | Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease NCT05602727 | Merck Sharp & Dohme LLC | Phase 2 |
| Recruiting | Safety and Target Engagement of Centella Asiatica in Cognitive Impairment NCT05591027 | Oregon Health and Science University | Phase 1 |
| Completed | A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Du NCT05619692 | Supernus Pharmaceuticals, Inc. | Phase 2 |
| Recruiting | Effects of Combined 40 Hz Audio-visual Stimulation and Cognitive Games on Alzheimer's Disease NCT06595511 | Istanbul Medipol University Hospital | N/A |
| Unknown | A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer NCT05607615 | Cyclo Therapeutics, Inc. | Phase 2 |
| Recruiting | Study on the Effect of 40 Hz Non-Invasive Light Therapy System NCT05260177 | Zealand University Hospital | N/A |
| Terminated | A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease NCT05476783 | TrueBinding, Inc. | Phase 2 |
| Active Not Recruiting | A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1) NCT05463731 | Eli Lilly and Company | Phase 3 |
| Completed | Memesto Wearable Repetitive Message and Music Therapy Device Music Therapy Device That Senses and Reduces Agit NCT06596278 | Edgewater Safety Systems, Inc. | N/A |
| Completed | MK-8189 Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation NCT05227118 | Merck Sharp & Dohme LLC | Phase 1 |
| Withdrawn | A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheime NCT04187547 | Cerecin | Phase 3 |
| Recruiting | A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) NCT05462106 | AC Immune SA | Phase 1 / Phase 2 |
| Terminated | A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease NCT05310071 | Biogen | Phase 3 |
| Completed | Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disea NCT05423522 | Medesis Pharma SA | Phase 2 |
| Enrolling By Invitation | Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases NCT06731842 | Karolinska Institutet | N/A |
| Terminated | Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease NCT05352763 | Cassava Sciences, Inc. | Phase 2 |
| Active Not Recruiting | Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease NCT05267535 | Neurim Pharmaceuticals Ltd. | Phase 2 / Phase 3 |
| Completed | Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adul NCT05363293 | Alzamend Neuro, Inc. | Phase 1 / Phase 2 |
| Unknown | Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease NCT05176704 | Innodem Neurosciences | — |
| Completed | "Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program" NCT05350410 | Alzheimer's Disease Cooperative Study (ADCS) | N/A |
| Unknown | Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects NCT04141150 | APRINOIA Therapeutics, LLC | Phase 2 |
| Unknown | Development of Multimodal Fusion Warning System and Non-invasive Techniques for Early Alzheimer's Detection. NCT05978830 | First Affiliated Hospital of Zhejiang University | N/A |
| Recruiting | A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment NCT05040217 | Mark Tuszynski | Phase 1 |
| Active Not Recruiting | Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures NCT05153941 | Altoida | — |
| Completed | [18F]APN-1607 PET in Subjects With AD Compared to HC NCT05542953 | APRINOIA Therapeutics | Phase 3 |
| Completed | Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia NCT05519137 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Association of Cognition With Functional Mobility in People With Alzheimer's Disease NCT05113732 | Istanbul University - Cerrahpasa | — |
| Recruiting | Personalized Management of Psycho-behavioral Symptoms in Alzheimer's Disease: Impact on Health Resources Use NCT04820127 | University Hospital, Toulouse | N/A |
| Completed | Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Partici NCT05074498 | TrueBinding, Inc. | Phase 1 / Phase 2 |
| Recruiting | PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease NCT04396873 | National Institute of Mental Health (NIMH) | Phase 1 |
| Unknown | Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM® NCT04954534 | Samsung Medical Center | N/A |
| Unknown | Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease NCT04926272 | First Affiliated Hospital of Fujian Medical University | Phase 2 |
| Completed | The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment NCT04073628 | Icahn School of Medicine at Mount Sinai | N/A |
| Completed | A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive NCT04867616 | UCB Biopharma SRL | Phase 2 |
| Completed | A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects NCT04973189 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Greater-Bay-Area Healthy Aging Brain Study (GHABS) NCT06183658 | Shenzhen Bay Laboratory | — |
| Completed | Autobiographical Memory NCT04584138 | Nantes University Hospital | — |
| Completed | Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413) NCT04730635 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005) NCT04308304 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Self-Management Intervention: Considering Needs & Preferences of Dementia Caregivers (Caregiver Career Study) NCT04603482 | Case Western Reserve University | N/A |
| Completed | New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study NCT04426539 | American College of Radiology | — |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants NCT04476303 | BeyondBio Inc. | Phase 1 |
| Recruiting | Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis NCT04850053 | Capital Medical University | — |
| Withdrawn | Induction and Recognition of Emotions NCT04353947 | University of Valencia | — |
| Terminated | A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Pre NCT04241068 | Biogen | Phase 3 |
| Unknown | A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's NCT04137926 | Shanghai Mental Health Center | N/A |
| Unknown | A Noval Tau Tracer in Young Onset Dementia NCT04248270 | Chang Gung Memorial Hospital | Phase 1 / Phase 2 |
| Unknown | Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease NCT04271163 | NeuroEM Therapeutics, Inc. | Phase 1 / Phase 2 |
| Unknown | Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir ( NCT04305210 | Chang Gung Memorial Hospital | Phase 2 |
| Terminated | Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease NCT02359864 | Corewell Health East | N/A |
| Withdrawn | Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) NCT03740178 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) NCT04666077 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Efficacy of Hypnosis on Pain and Anxiety During Lumbar Puncture for Etiological Diagnosis of Cognitive Impairm NCT04368572 | Gérond'if | N/A |
| Completed | A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With NCT04445831 | AC Immune SA | Phase 1 / Phase 2 |
| Recruiting | The Role of Concomitant Diseases in Postoperative Complications Risk Stratification. NCT03945968 | Russian Federation of Anesthesiologists and Reanimatologists | — |
| Completed | Effect of REST in the Alzheimer Disease Continuum NCT03884023 | Dongzhimen Hospital, Beijing | — |
| Terminated | A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Sub NCT03935568 | Samus Therapeutics, Inc. | Phase 1 |
| Withdrawn | Brain Sleep Deprivation MRI Effects (BEDTIME) NCT02741505 | NYU Langone Health | N/A |
| Unknown | Sleep in Adults With Down Syndrome and Alzheimer's Disease NCT03942341 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Completed | Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects NCT03817684 | Tetra Discovery Partners | Phase 2 |
| Completed | Trial of Rifaximin in Probable Alzheimer's Disease NCT03856359 | Duke University | Phase 2 |
| Unknown | Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects NCT04169126 | Chang Gung Memorial Hospital | Phase 2 |
| Unknown | Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease NCT04174287 | Chang Gung Memorial Hospital | Phase 2 |
| Terminated | An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD) NCT03712787 | AbbVie | Phase 2 |
| Completed | In-Home Technology for Dementia Caregivers NCT03828383 | University of California, Berkeley | N/A |
| Completed | Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administratio NCT05787028 | South China Center For Innovative Pharmaceuticals | Phase 1 |
| Completed | A Study of Semorinemab in Patients With Moderate Alzheimer's Disease NCT03828747 | Genentech, Inc. | Phase 2 |
| Completed | Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 NCT03838185 | Abrexa Pharmaceuticals, Inc. | Phase 1 |
| Unknown | Evaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzhe NCT03360552 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients Wi NCT02989402 | Novartis Pharmaceuticals | Phase 4 |
| Terminated | A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild A NCT03639987 | Biogen | Phase 2 |
| Unknown | Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease NCT03790982 | Zhejiang Hisun Pharmaceutical Co. Ltd. | Phase 2 |
| Active Not Recruiting | Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia NCT03672201 | Centre for Addiction and Mental Health | N/A |
| Completed | Prazosin for Agitation in Alzheimer's Disease NCT03710642 | Alzheimer's Disease Cooperative Study (ADCS) | Phase 2 |
| Completed | A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subject NCT03594123 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
| Withdrawn | A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participa NCT03316898 | Allergan | Phase 1 |
| Completed | Effects of Group Music Therapy Interventions on Alzheimer's Disease Patients: a Three-arm Randomized Controlle NCT04761497 | Universidad Católica San Antonio de Murcia | N/A |
| Recruiting | The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease NCT05020106 | Capital Medical University | — |
| Recruiting | Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease NCT03019757 | Douglas Scharre | — |
| Terminated | An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-3 NCT03531710 | United Neuroscience Ltd. | Phase 2 |
| Terminated | Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD) NCT02033941 | Hillel Grossman | Phase 2 |
| Terminated | A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients NCT03668405 | H. Lundbeck A/S | Phase 1 |
| Terminated | Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease NCT03352557 | Biogen | Phase 2 |
| Completed | Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training NCT03503669 | University of California, Los Angeles | N/A |
| Unknown | Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia NCT03441516 | Yuhan Corporation | Phase 4 |
| Terminated | An Open-Label Crenezumab Study in Participants With Alzheimer's Disease NCT03491150 | Hoffmann-La Roche | Phase 3 |
| Completed | An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease NCT02537626 | Erchonia Corporation | N/A |
| Completed | A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal D NCT03438604 | Corium, Inc. | Phase 1 |
| Completed | A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) NCT03432195 | Corium, Inc. | Phase 1 |
| Completed | 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls NCT03625128 | Chang Gung Memorial Hospital | EARLY_Phase 1 |
| Completed | Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care NCT03456349 | Nxera Pharma UK Limited | Phase 1 |
| Completed | A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept® NCT03259958 | Corium, Inc. | Phase 1 |
| Unknown | Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease NCT02672306 | South China Research Center for Stem Cell and Regenerative Medicine | Phase 1 / Phase 2 |
| Terminated | A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Dise NCT03289143 | Genentech, Inc. | Phase 2 |
| Withdrawn | Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volu NCT02130661 | GlaxoSmithKline | Phase 1 |
| Terminated | Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease NCT03307993 | H. Lundbeck A/S | Phase 1 |
| Active Not Recruiting | Tango for Alzheimer's Disease Patients' Caregivers NCT03269149 | Emory University | N/A |
| Completed | Genistein as a Possible Treatment for Alzheimer's Disease. NCT01982578 | Fundación para la Investigación del Hospital Clínico de Valencia | N/A |
| Completed | MR Guided tDCS in Alzheimer's Disease NCT03325205 | University of Tromso | N/A |
| Recruiting | Retinal Imaging in Neurodegenerative Disease NCT03233646 | Duke University | — |
| Completed | Nicotinamide as an Early Alzheimer's Disease Treatment NCT03061474 | University of California, Irvine | Phase 2 |
| Completed | Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid NCT02719327 | VA Office of Research and Development | Phase 2 / Phase 3 |
| Completed | Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial. NCT03172117 | Medipost Co Ltd. | Phase 1 / Phase 2 |
| Completed | Visuospatial Attention, Eye Movements and Instrumental Activities of Daily Living (IADLs) in Alzheimer's Disea NCT02941289 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression NCT02849639 | Daniela Moga | EARLY_Phase 1 |
| Completed | Auditory Rehabilitation and Cognition in Alzheimer Patients NCT03002142 | University Hospital, Tours | N/A |
| Terminated | A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mil NCT03114657 | Hoffmann-La Roche | Phase 3 |
| Terminated | A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia NCT02972658 | AstraZeneca | Phase 3 |
| Completed | Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease NCT02925650 | Annovis Bio Inc. | Phase 1 / Phase 2 |
| Completed | Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease NCT02792257 | Johns Hopkins University | Phase 2 |
| Recruiting | Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants NCT02685969 | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | — |
| Completed | Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease NCT03056729 | Biogen | Phase 1 |
| Unknown | The Locus Coeruleus and Memory NCT02363504 | Maastricht University Medical Center | — |
| Withdrawn | BAC in Patient With Alzheimer's Disease or Vascular Dementia NCT02467413 | Charsire Biotechnology Corp. | Phase 2 |
| Completed | A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease NCT02880956 | AbbVie | Phase 2 |
| Completed | Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease NCT02947893 | Georgetown University | Phase 2 |
| Terminated | 2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension) NCT02916056 | vTv Therapeutics | Phase 3 |
| Completed | 18F-AV-1451 High Resolution Autopsy Study NCT02350634 | Avid Radiopharmaceuticals | Phase 1 |
| Completed | Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's NCT02908815 | University of Manitoba | N/A |
| Active Not Recruiting | Early Identification of Markers in Alzheimer's Families / ALFA NCT02485730 | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | — |
| Terminated | A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzhei NCT02956486 | Eisai Co., Ltd. | Phase 3 |
| Completed | An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-893 NCT02910739 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease NCT02600130 | Longeveron Inc. | Phase 1 |
| Completed | Z-Drugs for Sleep Disorders in Alzheimer's Disease NCT03075241 | Brasilia University Hospital | Phase 3 |
| Completed | Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia NCT02910102 | Axovant Sciences Ltd. | Phase 2 |
| Completed | Optimizing Dementia Care NCT02585232 | VA Office of Research and Development | N/A |
| Withdrawn | CPC-201 Alzheimer's Disease Type Dementia: PET Study NCT02860065 | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | Phase 2 |
| Unknown | Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women NCT02868905 | Central Hospital, Nancy, France | N/A |
| Unknown | Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease NCT02899091 | CHABiotech CO., Ltd | Phase 1 / Phase 2 |
| Completed | Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease NCT02907567 | Cognition Therapeutics | Phase 1 / Phase 2 |
| Unknown | A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease NCT02912936 | University of British Columbia | N/A |
| Completed | Adaptive Cognitive Training in Healthy Older Adults NCT02205710 | Bruyère Health Research Institute. | N/A |
| Completed | Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 NCT02795780 | Avid Radiopharmaceuticals | Phase 2 |
| Completed | Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheim NCT02792179 | Hoffmann-La Roche | Phase 1 |
| Terminated | A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia NCT02783573 | AstraZeneca | Phase 3 |
| Terminated | Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial NCT02781220 | University of Utah | — |
| Unknown | Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Adminis NCT02928211 | Cognoptix, Inc. | Phase 1 |
| Completed | Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases. NCT02750982 | Brown, Theodore R., M.D., MPH | N/A |
| Terminated | Imaging Tau in Alzheimer's Disease and Normal Aging NCT02884492 | William Charles Kreisl | Phase 2 |
| Completed | A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease NCT02820896 | Genentech, Inc. | Phase 1 |
| Terminated | A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia NCT02791191 | Eli Lilly and Company | Phase 2 |
| Terminated | A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease NCT02760602 | Eli Lilly and Company | Phase 3 |
| Completed | Imaging Inflammation in Alzheimer's Disease NCT02831283 | Patrick Lao | Phase 2 |
| Completed | A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects NCT02840279 | Tetra Discovery Partners | Phase 1 |
| Completed | Biomarkers in Neural Disorders NCT02761707 | University of Pennsylvania | — |
| Unknown | The Study of Mechanism of Alzheimer's Disease Using Acupuncture Based on fMRI NCT02759159 | Xuanwu Hospital, Beijing | N/A |
| Completed | Implications for Management of PET Amyloid Classification Technology NCT02778971 | University of Utah | — |
| Completed | Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application NCT02848404 | Seoul National University Bundang Hospital | N/A |
| Recruiting | PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Dise NCT02649985 | Brigham and Women's Hospital | Phase 1 / Phase 2 |
| Completed | Control and Intervention Programme on Alzheimer's Disease Risk Factors NCT02772523 | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | N/A |
| Unknown | Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease NCT02752750 | Medical University of Graz | — |
| Terminated | Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's NCT02769000 | Virginia Commonwealth University | N/A |
| Unknown | Neurostimulation and Cognitive Intervention in Alzheimer's Disease NCT02772185 | Federal University of Paraíba | Phase 2 / Phase 3 |
| Completed | EEG/ERP Longitudinal Study in Alzheimer's Disease (AD) NCT02769234 | Neuronetrix, Inc. | — |
| Completed | Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants NCT02782975 | Biogen | Phase 1 |
| Terminated | 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Ext NCT02586909 | Axovant Sciences Ltd. | Phase 3 |
| Completed | A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD) NCT02754830 | Eli Lilly and Company | Phase 1 |
| Completed | Patient-Centred Innovations for Persons With Multimorbidity - Quebec NCT02789800 | Université de Sherbrooke | N/A |
| Completed | Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease NCT02787746 | Beijing Friendship Hospital | Phase 4 |
| Completed | Behavioral Expressions in Alzheimer's Disease NCT02719834 | University of Florida | — |
| Terminated | A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild NCT02670083 | Hoffmann-La Roche | Phase 3 |
| Completed | 24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease NCT02579252 | Axon Neuroscience SE | Phase 2 |
| Completed | Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline NCT02921672 | University of Kansas Medical Center | N/A |
| Completed | DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepe NCT02711683 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Completed | An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease NCT02756858 | Anavex Life Sciences Corp. | Phase 2 |
| Unknown | Omental Transposition Surgery for Mild Alzheimer's Disease NCT02349191 | Bariatric Medicine Institute, Salt Lake City, UT | N/A |
| Completed | Caregiver Burden and Depression: Caring for Those Who Care for Others NCT02690896 | University of Central Florida | N/A |
| Completed | Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil). NCT02695004 | Dongkook Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild C NCT02778438 | Quintiles, Inc. | — |
| Completed | Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study NCT02420756 | American College of Radiology | — |
| Completed | Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Do NCT02710188 | Nxera Pharma UK Limited | Phase 1 |
| Recruiting | BEAM: Brain-Eye Amyloid Memory Study NCT02524405 | Sunnybrook Health Sciences Centre | — |
| Completed | Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS NCT02537496 | Centre for Addiction and Mental Health | N/A |
| Completed | Patient-Centred Innovations for Persons With Multimorbidity - Ontario NCT02742597 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Di NCT02656498 | Jae Seung Kim | Phase 2 |
| Completed | [11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001) NCT02621606 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Apathy in Dementia Methylphenidate Trial 2 NCT02346201 | Johns Hopkins Bloomberg School of Public Health | Phase 3 |
| Completed | Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose) NCT02537938 | NeuroGenetic Pharmaceuticals Inc | Phase 1 |
| Completed | Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Diseas NCT02670993 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Al NCT02640092 | Genentech, Inc. | Phase 1 |
| Completed | Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy NCT02686216 | Chang Gung Memorial Hospital | Phase 1 |
| Completed | BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects NCT02648672 | Tetra Discovery Partners | Phase 1 |
| Unknown | EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors NCT02623764 | Landspitali University Hospital | — |
| Terminated | Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 i NCT02573740 | AbbVie | Phase 1 |
| Terminated | A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Di NCT02614131 | Eli Lilly and Company | Phase 1 |
| Completed | Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading. NCT02557464 | Centre Hospitalier Universitaire de Nice | N/A |
| Withdrawn | Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer' NCT02912169 | Ageless Regenerative Institute | Phase 1 / Phase 2 |
| Completed | Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) NCT02615002 | Neurim Pharmaceuticals Ltd. | Phase 2 |
| Completed | Role of Hypoxia Ans Sleep Fragmentation in Alzheimer's Disease. and Sleep Fragmentation. NCT02814045 | Sociedad Española de Neumología y Cirugía Torácica | — |
| Completed | A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease NCT02431468 | Neurotrope Bioscience, Inc. | Phase 2 |
| Completed | [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) NCT02562989 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Pati NCT02551809 | United Neuroscience Ltd. | Phase 2 |
| Completed | Brain Sleep Clearance of Amyloid-Beta Peptides NCT02474251 | NYU Langone Health | N/A |
| Completed | Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease NCT02709356 | Université de Sherbrooke | N/A |
| Completed | Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention NCT02347202 | NYU Langone Health | N/A |
| Completed | Monetary Cost of Alzheimer's Disease in China NCT02694445 | Beijing Friendship Hospital | — |
| Completed | Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MIN NCT02585934 | Axovant Sciences Ltd. | Phase 3 |
| Completed | Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjec NCT02546310 | Nxera Pharma UK Limited | Phase 1 |
| Completed | Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease NCT02547818 | AZTherapies, Inc. | Phase 3 |
| Terminated | 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease NCT02484547 | Biogen | Phase 3 |
| Completed | Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease NCT05040048 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Terminated | Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease NCT02521558 | Boston University | N/A |
| Completed | 18F-AV-1451 Autopsy Study NCT02516046 | Avid Radiopharmaceuticals | Phase 3 |